-
Je něco špatně v tomto záznamu ?
Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy
J. Neupauerová, K. Štěrbová, M. Vlčková, V. Sebroňová, T. Maříková, M. Krůtová, S. David, P. Kršek, M. Žaliová, P. Seeman, P. Laššuthová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu kazuistiky, časopisecké články
PubMed
28872899
DOI
10.1089/gtmb.2017.0110
Knihovny.cz E-zdroje
- MeSH
- epilepsie genetika MeSH
- exony MeSH
- genetická variace genetika MeSH
- křeče u dětí genetika MeSH
- lidé MeSH
- mutace MeSH
- předškolní dítě MeSH
- protein-serin-threoninkinasy genetika metabolismus MeSH
- Rettův syndrom genetika MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
BACKGROUND: Variants in the human X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been reported as being etiologically associated with early infantile epileptic encephalopathy type 2 (EIEE2). We report on two patients, a boy and a girl, with EIEE2 that present with early onset epilepsy, hypotonia, severe intellectual disability, and poor eye contact. METHODS: Massively parallel sequencing (MPS) of a custom-designed gene panel for epilepsy and epileptic encephalopathy containing 112 epilepsy-related genes was performed. Sanger sequencing was used to confirm the novel variants. For confirmation of the functional consequence of an intronic CDKL5 variant in patient 2, an RNA study was done. RESULTS: DNA sequencing revealed de novo variants in CDKL5, a c.2578C>T (p. Gln860*) present in a hemizygous state in a 3-year-old boy, and a potential splice site variant c.463+5G>A in heterozygous state in a 5-year-old girl. Multiple in silico splicing algorithms predicted a highly reduced splice site score for c.463+5G>A. A subsequent mRNA study confirmed an aberrant shorter transcript lacking exon 7. CONCLUSIONS: Our data confirmed that variants in the CDKL5 are associated with EIEE2. There is credible evidence that the novel identified variants are pathogenic and, therefore, are likely the cause of the disease in the presented patients. In one of the patients a stop codon variant is predicted to produce a truncated protein, and in the other patient an intronic variant results in aberrant splicing.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010352
- 003
- CZ-PrNML
- 005
- 20180426103636.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/gtmb.2017.0110 $2 doi
- 035 __
- $a (PubMed)28872899
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Neupauerová, Jana $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 245 10
- $a Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy / $c J. Neupauerová, K. Štěrbová, M. Vlčková, V. Sebroňová, T. Maříková, M. Krůtová, S. David, P. Kršek, M. Žaliová, P. Seeman, P. Laššuthová,
- 520 9_
- $a BACKGROUND: Variants in the human X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been reported as being etiologically associated with early infantile epileptic encephalopathy type 2 (EIEE2). We report on two patients, a boy and a girl, with EIEE2 that present with early onset epilepsy, hypotonia, severe intellectual disability, and poor eye contact. METHODS: Massively parallel sequencing (MPS) of a custom-designed gene panel for epilepsy and epileptic encephalopathy containing 112 epilepsy-related genes was performed. Sanger sequencing was used to confirm the novel variants. For confirmation of the functional consequence of an intronic CDKL5 variant in patient 2, an RNA study was done. RESULTS: DNA sequencing revealed de novo variants in CDKL5, a c.2578C>T (p. Gln860*) present in a hemizygous state in a 3-year-old boy, and a potential splice site variant c.463+5G>A in heterozygous state in a 5-year-old girl. Multiple in silico splicing algorithms predicted a highly reduced splice site score for c.463+5G>A. A subsequent mRNA study confirmed an aberrant shorter transcript lacking exon 7. CONCLUSIONS: Our data confirmed that variants in the CDKL5 are associated with EIEE2. There is credible evidence that the novel identified variants are pathogenic and, therefore, are likely the cause of the disease in the presented patients. In one of the patients a stop codon variant is predicted to produce a truncated protein, and in the other patient an intronic variant results in aberrant splicing.
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a epilepsie $x genetika $7 D004827
- 650 _2
- $a exony $7 D005091
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická variace $x genetika $7 D014644
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a protein-serin-threoninkinasy $x genetika $x metabolismus $7 D017346
- 650 _2
- $a Rettův syndrom $x genetika $7 D015518
- 650 _2
- $a křeče u dětí $x genetika $7 D013036
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Štěrbová, Katalin $u 2 Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Vlčková, Markéta $u 3 Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Sebroňová, Věra $u 2 Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Maříková, Tat'ána $u 3 Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Krůtová, Marcela $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a David, Staněk $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Kršek, Pavel $u 2 Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Žaliová, Markéta $u 4 CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Seeman, Pavel $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 700 1_
- $a Laššuthová, Petra $u 1 DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol , Prague, Czech Republic .
- 773 0_
- $w MED00174670 $t Genetic testing and molecular biomarkers $x 1945-0257 $g Roč. 21, č. 10 (2017), s. 613-618
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28872899 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180426103747 $b ABA008
- 999 __
- $a ok $b bmc $g 1287837 $s 1007164
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 21 $c 10 $d 613-618 $e 20170905 $i 1945-0257 $m Genetic testing and molecular biomarkers $n Genet Test Mol Biomarkers $x MED00174670
- LZP __
- $a Pubmed-20180404